HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

John Paul Mitchell Line Among Contract Manufacturer's Bacteria-Linked Recalls

This article was originally published in The Rose Sheet

Executive Summary

Topical administration of products Boochi Laboratories is recalling could result in potentially serious bacterial infections in immuno-compromised persons. All lots within expiry of X-Jow Pain Gel, Acne Shave moisturizer and Shave Cream with Acne Shield and Cremo, Eufora and John Paul Mitchell skin and hair care products are the latest recalls by the firm.

You may also be interested in...



'Blood Disorders' Supplement, More Bocchi Labs Hair Care Products Recalled

McDaniel Life-Line recalls its Indian Herb supplement after FDA determined it was marketed without an NDA for claims including "blood disorders." For third time in less than a year, John Paul Mitchell Systems brand and other shampoos recalled by manufacturer Bocchi Labs due to potential contamination; other health, beauty and wellness product recalls.

Health, Beauty And Wellness News: Medline Remedy Contamination, GNC Proxy

‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation

CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121636

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel